Motilal Oswal's research report on Dalmia Bharat
Dalmia Bharat (DALBHARA)’s key markets (the South and East regions) witnessed a higher price correction (down 8-9% QoQ) vs. other regions (down 3-7% QoQ) in 4QFY24. However, the company is likely to report double-digit volume growth in 4QFY24, supported by healthy demand and market share gains. We cut our EBITDA estimates by 4%/8%/8% for FY24/FY25/FY26 due to weak pricing, which was partly offset by higher volume growth and cost reduction initiatives. Further, a delay in the acquisition of Jaiprakash Associates (JPA)’s cement assets (announced in Dec’22) remains an overhang on the stock. The approval process from various banks is pending and is taking longer than anticipated. However, DALBHARA’s organic expansion plans are on track. It will add clinker and cement capacities of 4.9mtpa each through a mix of greenfield and brownfield expansions by FY25.
Outlook
The stock has corrected 15% in the last three months due to concerns of lower profitability because of a decline in cement prices. We value the stock at 12x FY26E (earlier 13x) EV/EBITDA to arrive at our revised TP of INR2,500 (earlier INR2,800). The stock offers an upside potential of 25% from current levels. Reiterate BUY.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.